🏛️ Verified NIH Record • Updated 2025-05-21
Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs (NCT06997185)
🟢 Recruiting Observational / Diagnostic 📋 Clinical Research Protocol Sponsor: London School of Economics and Political Science
🩺 Plain-English Summary (8th-Grade Level)
This nationally representative randomized survey of US adults will evaluate the effect of using brief statements to communicate different sources of uncertainty about the benefits and harms of new cancer drugs on participants' decisions and understanding.
Who can join: Review the eligibility criteria below.
Location: Harvard Medical School and Harvard Pilgrim Health Care Institute — Boston, Massachusetts
Age range: 18 Years
🧪 Interventions in This Study
- Statement communicating uncertainty with a single arm trial (OTHER)
- Statement communicating uncertainty with limited study duration (OTHER)
- Statement communicating uncertainty with a limited study population (OTHER)
- Statement communicating uncertainty with an unvalidated surrogate endpoint (OTHER)
- Statement communicating uncertainty with treatment effect size (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Harvard Medical School and Harvard Pilgrim Health Care Institute — Boston, Massachusetts
📞 Contact the Study Coordinator
Phone: (617) 201-1718
Email: a.j.cherla@lse.ac.uk
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cancer
- Ovarian Tissue Cryopreservation in Children — Rochester, Minnesota
- A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study — Aurora, Colorado
- Ex Onc SLED: A Study Utilizing A Weighted Sled for Horizontal Resistance Training — Pittsburgh, Pennsylvania
- An Internet-based Program to Help Cancer Survivors Manage Pain — Fort Smith, Arkansas
- Identification of Patients With Age-Related Clonal Hematopoiesis (ARCH) Among Cancer Survivors — Toronto, Ontario
- Researching the Effect of Aerobic Exercise on Cancer — Los Angeles, California
Explore by condition: All Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.